The overall goal of this project is to develop promising drug candidate leads using a new drug design paradigm based on initial three-dimensional RNA-structure-based computational screening of about 255,000 commercially available compounds for binding to selected RNA targets using the three-dimensional structure of portions of the HIV-1 genome. Specifically, the transactivation response element (TAR) and the dimer linkage site (DLS) are proposed as targets. The latter is a novel target for drug design. Good computational """"""""hits"""""""" will be tested for inhibition in functional assays. The best of these will be utilized in NMR studies to verify the mode of binding to the RNA target. The best candidates will be water-soluble, nonpeptide, nonnucleotide organic compounds generally with molecular weight less than 500 daltons, but it may be necessary to consider slightly larger compounds as leads. The NMR structural studies of complexes formed with potential leads and their RNA targets should yield insight into features governing affinity and specificity. Promising leads will be selected for further development via computational and experimental combinatorial chemistry. Some further development of the methodology is proposed.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI046967-02
Application #
6349932
Study Section
Special Emphasis Panel (ZRG1-AARR-3 (01))
Program Officer
Miller, Roger H
Project Start
2000-01-01
Project End
2004-12-31
Budget Start
2001-01-01
Budget End
2001-12-31
Support Year
2
Fiscal Year
2001
Total Cost
$251,179
Indirect Cost
Name
University of California San Francisco
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Chen, Chiung-Kuang; Leung, Siegfried S F; Guilbert, Christophe et al. (2010) Structural characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei bound to the antifungal drugs posaconazole and fluconazole. PLoS Negl Trop Dis 4:e651
Chung, Janet; Ulyanov, Nikolai B; Guilbert, Christophe et al. (2010) Binding characteristics of small molecules that mimic nucleocapsid protein-induced maturation of stem-loop 1 of HIV-1 RNA. Biochemistry 49:6341-51
Ulyanov, Nikolai B; James, Thomas L (2010) RNA structural motifs that entail hydrogen bonds involving sugar-phosphate backbone atoms of RNA. New J Chem 34:910-917
Lang, P Therese; Brozell, Scott R; Mukherjee, Sudipto et al. (2009) DOCK 6: combining techniques to model RNA-small molecule complexes. RNA 15:1219-30
Du, Zhihua; Fenn, Sebastian; Tjhen, Richard et al. (2008) Structure of a construct of a human poly(C)-binding protein containing the first and second KH domains reveals insights into its regulatory mechanisms. J Biol Chem 283:28757-66
Pinto, Irene Gomez; Guilbert, Christophe; Ulyanov, Nikolai B et al. (2008) Discovery of ligands for a novel target, the human telomerase RNA, based on flexible-target virtual screening and NMR. J Med Chem 51:7205-15
Guilbert, Christophe; James, Thomas L (2008) Docking to RNA via root-mean-square-deviation-driven energy minimization with flexible ligands and flexible targets. J Chem Inf Model 48:1257-68
Du, Zhihua; Lee, John K; Tjhen, Richard et al. (2008) Structural and biochemical insights into the dicing mechanism of mouse Dicer: a conserved lysine is critical for dsRNA cleavage. Proc Natl Acad Sci U S A 105:2391-6
Chung, Janet; Mujeeb, Anwer; Jiang, Yongying et al. (2008) A small molecule, Lys-Ala-7-amido-4-methylcoumarin, facilitates RNA dimer maturation of a stem-loop 1 transcript in vitro: structure-activity relationship of the activator. Biochemistry 47:8148-56
Du, Zhihua; Lee, John K; Fenn, Sebastian et al. (2007) X-ray crystallographic and NMR studies of protein-protein and protein-nucleic acid interactions involving the KH domains from human poly(C)-binding protein-2. RNA 13:1043-51

Showing the most recent 10 out of 23 publications